T-1123 (Thermalin/Sanofi)

N/A

Report date: 2025/01/26 15:55:55

Base Information

Drug NameT-1123 (Thermalin/Sanofi)
Drug Alias Namerecombinant protein insulin (Thermalin/Sanofi)stabilized, ultra-rapid insulin (Thermalin/Sanofi)insulin receptor agonist (Thermalin/Sanofi)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionInsulin ligandInsulin receptor agonists
TargetsInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThermalin Inc
China Registration ClassN/A

Develop Information

Active CompaniesThermalin IncSanofi
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A